ABO DIAG has been acquired by DIAGAST
The private shareholders and investment funds Succes Eur. and Aqui Invest, based in France, have sold ABO DIAG to DIAGAST for US$6.5 million.
ABO DIAG was founded in 2008 by its CEO, Najim Chaibi. Located in the technopolis of Montesquieu, the company is based on the research and development of diagnostic devices dedicated to blood transfusion and more widely to immuno-haematology. ABO DIAG is a pioneer in the field of research of new solutions for haematological diagnosis. The company's patent protected technology is based on immunological detection in vertical flow with colored dots. This innovation provides higher sensibility and higher safety in diagnosis, thanks to a simple user procedure and with standardized results. ABO DIAG was awarded the First Prize of Innovation at JIB 2012 (Innovation of the year in Biology).
DIAGAST is the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions. Over the last 30 years, the company has developed unparalleled expertise and know-how in the transfusion sector.
Oaklins' team in France advised the seller in this transaction.


Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAcapo AS has been acquired by Longship AS
Oslo-based intellectual property advisory firm Onsagers, supported by Longship since May 2024, has acquired Acapo AS. By combining decades of expertise and global reach, this strategic acquisition unites two of Norway’s most reputable IP firms, enabling them to offer a comprehensive range of solutions in patents, trademarks and IP strategy. This milestone strengthens their position in building a best-in-class network for strategic IP management, marking a key step in their continued growth.
Learn more